These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. What exactly are the benefits of stimulants for ADHD? Advokat C. J Atten Disord; 2009 May; 12(6):495-8. PubMed ID: 19380518 [No Abstract] [Full Text] [Related]
5. Attention-deficit/hyperactivity disorder psychopharmacology for college students. Staufer WB, Greydanus DE. Pediatr Clin North Am; 2005 Feb; 52(1):71-84, viii. PubMed ID: 15748925 [Abstract] [Full Text] [Related]
6. Chronic Ritalin use and cancer. Goldstein S. J Atten Disord; 2010 Mar; 13(5):441. PubMed ID: 20190147 [No Abstract] [Full Text] [Related]
7. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH. J Clin Psychiatry; 2003 Mar; 64 Suppl 11():14-8. PubMed ID: 14529325 [Abstract] [Full Text] [Related]
8. Attention deficit hyperactivity disorder and substance use disorders. Szobot CM, Bukstein O. Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148 [Abstract] [Full Text] [Related]
9. [Off-label use: the case of methylphenidate (Ritalin)]. Fritze J, Schmauss M. Nervenarzt; 2002 Dec; 73(12):1210-2. PubMed ID: 12599339 [No Abstract] [Full Text] [Related]
10. Update on investigation of Ritalin conspiracy. J Psychosoc Nurs Ment Health Serv; 2001 Jan; 39(1):10. PubMed ID: 11197990 [No Abstract] [Full Text] [Related]
11. [Methylphenidate. A drug for attention deficit disorders to be used with precaution]. Taéron C. Rev Infirm; 2009 Jun; (151):47-9. PubMed ID: 19579855 [No Abstract] [Full Text] [Related]
13. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder. Pae CU. Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730 [No Abstract] [Full Text] [Related]
14. Pleasure and discipline in the uses of Ritalin. Keane H. Int J Drug Policy; 2008 Oct 30; 19(5):401-9. PubMed ID: 17884422 [Abstract] [Full Text] [Related]
15. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Leonard BE, McCartan D, White J, King DJ. Hum Psychopharmacol; 2004 Apr 30; 19(3):151-80. PubMed ID: 15079851 [No Abstract] [Full Text] [Related]
16. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'. Olders H. J Pediatr Psychol; 2009 Apr 30; 34(1):108-9; author reply 110-2. PubMed ID: 19136567 [No Abstract] [Full Text] [Related]
19. Attention deficit hyperactivity disorder across the lifespan: the child, adolescent, and adult. Greydanus DE, Pratt HD, Patel DR. Dis Mon; 2007 Feb 30; 53(2):70-131. PubMed ID: 17386306 [Abstract] [Full Text] [Related]
20. Methylphenidate-induced obsessive-compulsiveness. Kouris S. J Am Acad Child Adolesc Psychiatry; 1998 Feb 30; 37(2):135. PubMed ID: 9473905 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]